These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 18079194

  • 21. Effect of zinc on regulation of insulin-like growth factor signaling in human androgen-independent prostate cancer cells.
    Banudevi S, Senthilkumar K, Sharmila G, Arunkumar R, Vijayababu MR, Arunakaran J.
    Clin Chim Acta; 2010 Feb; 411(3-4):172-8. PubMed ID: 19913001
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of IGF-1 signaling by genistein: modulation of E-cadherin expression and downregulation of β-catenin signaling in hormone refractory PC-3 prostate cancer cells.
    Lee J, Ju J, Park S, Hong SJ, Yoon S.
    Nutr Cancer; 2012 Feb; 64(1):153-62. PubMed ID: 22098108
    [Abstract] [Full Text] [Related]

  • 23. Tyrosine kinase-independent activation of extracellular-regulated kinase (ERK) 1/2 by the insulin-like growth factor-1 receptor.
    Perrault R, Wright B, Storie B, Hatherell A, Zahradka P.
    Cell Signal; 2011 Apr; 23(4):739-46. PubMed ID: 21215800
    [Abstract] [Full Text] [Related]

  • 24. Insulin-like growth factor-I (IGF-I)-dependent activation of pp42/44 mitogen-activated protein kinase occurs independently of IGF-I receptor kinase activation and IRS-1 tyrosine phosphorylation.
    Yau L, Lukes H, McDiarmid H, Werner J, Zahradka P.
    Eur J Biochem; 1999 Dec; 266(3):1147-57. PubMed ID: 10583412
    [Abstract] [Full Text] [Related]

  • 25. Effects of insulin and insulin-like growth factor 1 on osteoblast proliferation and differentiation: differential signalling via Akt and ERK.
    Zhang W, Shen X, Wan C, Zhao Q, Zhang L, Zhou Q, Deng L.
    Cell Biochem Funct; 2012 Jun; 30(4):297-302. PubMed ID: 22249904
    [Abstract] [Full Text] [Related]

  • 26. Dexamethasone enhances insulin-like growth factor-I effects on skeletal muscle cell proliferation. Role of specific intracellular signaling pathways.
    Giorgino F, Smith RJ.
    J Clin Invest; 1995 Sep; 96(3):1473-83. PubMed ID: 7544807
    [Abstract] [Full Text] [Related]

  • 27. Involvement of Raf-1 kinase and protein kinase C zeta in insulin-like growth factor I-induced brown adipocyte mitogenic signaling cascades: inhibition by cyclic adenosine 3',5'-monophosphate.
    Valverde AM, Teruel T, Lorenzo M, Benito M.
    Endocrinology; 1996 Sep; 137(9):3832-41. PubMed ID: 8756554
    [Abstract] [Full Text] [Related]

  • 28. NO donor and MEK inhibitor synergistically inhibit proliferation and invasion of cancer cells.
    Furuhashi S, Sugita H, Takamori H, Horino K, Nakahara O, Okabe H, Miyake K, Tanaka H, Beppu T, Baba H.
    Int J Oncol; 2012 Mar; 40(3):807-15. PubMed ID: 22025280
    [Abstract] [Full Text] [Related]

  • 29. Insulin-like growth factor I induces preferential degradation of insulin receptor substrate-2 through the phosphatidylinositol 3-kinase pathway in human neuroblastoma cells.
    Kim B, van Golen CM, Feldman EL.
    Endocrinology; 2005 Dec; 146(12):5350-7. PubMed ID: 16150916
    [Abstract] [Full Text] [Related]

  • 30. Proteasomal degradation of IRS-2, but not IRS-1 by calcineurin inhibition: attenuation of insulin-like growth factor-I-induced GSK-3beta and ERK pathways in adrenal chromaffin cells.
    Satoh S, Yanagita T, Maruta T, Nemoto T, Yoshikawa N, Kobayashi H, Tono T, Wada A.
    Neuropharmacology; 2008 Jul; 55(1):71-9. PubMed ID: 18538359
    [Abstract] [Full Text] [Related]

  • 31. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation.
    Mur C, Arribas M, Benito M, Valverde AM.
    Endocrinology; 2003 Feb; 144(2):581-93. PubMed ID: 12538620
    [Abstract] [Full Text] [Related]

  • 32. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
    Batty IH, Fleming IN, Downes CP.
    Biochem J; 2004 May 01; 379(Pt 3):641-51. PubMed ID: 14769130
    [Abstract] [Full Text] [Related]

  • 33. IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3'-kinase.
    Myers MG, Sun XJ, Cheatham B, Jachna BR, Glasheen EM, Backer JM, White MF.
    Endocrinology; 1993 Apr 01; 132(4):1421-30. PubMed ID: 8384986
    [Abstract] [Full Text] [Related]

  • 34. IGF-I increases IGFBP-5 and collagen alpha1(I) mRNAs by the MAPK pathway in rat intestinal smooth muscle cells.
    Xin X, Hou YT, Li L, Schmiedlin-Ren P, Christman GM, Cheng HL, Bitar KN, Zimmermann EM.
    Am J Physiol Gastrointest Liver Physiol; 2004 May 01; 286(5):G777-83. PubMed ID: 15068962
    [Abstract] [Full Text] [Related]

  • 35. Insulin-like growth factor I receptor activity in human medulloblastomas.
    Del Valle L, Enam S, Lassak A, Wang JY, Croul S, Khalili K, Reiss K.
    Clin Cancer Res; 2002 Jun 01; 8(6):1822-30. PubMed ID: 12060623
    [Abstract] [Full Text] [Related]

  • 36. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
    Esposito DL, Blakesley VA, Koval AP, Scrimgeour AG, LeRoith D.
    Endocrinology; 1997 Jul 01; 138(7):2979-88. PubMed ID: 9202243
    [Abstract] [Full Text] [Related]

  • 37. Focal adhesion kinase mediates cell survival via NF-kappaB and ERK signaling pathways.
    Huang D, Khoe M, Befekadu M, Chung S, Takata Y, Ilic D, Bryer-Ash M.
    Am J Physiol Cell Physiol; 2007 Apr 01; 292(4):C1339-52. PubMed ID: 17135301
    [Abstract] [Full Text] [Related]

  • 38. Nitric oxide inhibits the proliferation and invasion of pancreatic cancer cells through degradation of insulin receptor substrate-1 protein.
    Sugita H, Kaneki M, Furuhashi S, Hirota M, Takamori H, Baba H.
    Mol Cancer Res; 2010 Aug 01; 8(8):1152-63. PubMed ID: 20663861
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of insulin-like growth factor-1 receptor and IRS-2 signaling by ethanol in SH-SY5Y neuroblastoma cells.
    Seiler AE, Ross BN, Rubin R.
    J Neurochem; 2001 Jan 01; 76(2):573-81. PubMed ID: 11208920
    [Abstract] [Full Text] [Related]

  • 40. Arg972 insulin receptor substrate-1 enhances tumor necrosis factor-α-induced apoptosis in osteoblasts.
    You Y, Liu S, Peng L, Long M, Deng H, Zhao H.
    Mol Med Rep; 2015 Jul 01; 12(1):255-60. PubMed ID: 25760103
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.